Status:
COMPLETED
Staccato: A Trial of CD4 Guided Treatment Interruption, Compared to Continuous Treatment, for HIV Infection
Lead Sponsor:
University Hospital, Geneva
Conditions:
HIV Infection
AIDS
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Treatment of HIV repairs the immune system, but continuous treatment is expensive and causes side effects. Would it not be better to treat intermittently, e.g. stop treatment when the immune system ha...
Detailed Description
Continuous treatment has been very successful in diminishing the diseases and deaths caused by HIV. However, continuous treatment is expensive. Intermittent treatment will always cost less than contin...
Eligibility Criteria
Inclusion
- CD4 lymphocyte count above 350/microliter and viral HIV1-RNA below 50 copies/ml on antiretroviral treatment.
Exclusion
- Virologic failure of treatment. Failure of treatment defined as a treatment switch motivated by high viral loads on treatment.
Key Trial Info
Start Date :
January 1 2002
Trial Type :
INTERVENTIONAL
End Date :
October 1 2005
Estimated Enrollment :
526 Patients enrolled
Trial Details
Trial ID
NCT00113126
Start Date
January 1 2002
End Date
October 1 2005
Last Update
November 29 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Infectious Diseases Unit - University Hospital
Geneva, Switzerland, 1205